StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) Extends Gain, Up 6.5%
November 14, 2022 12:06 PM
Moderna (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Tyson Foods, Walt Disney rise premarket; Oatly, Tesla, Hasbro fall
November 14, 2022 8:14 AM
Moderna's Omicron shots shows better immune response than original COVID vaccine
November 14, 2022 7:05 AM
Moderna's (MRNA) BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants
November 14, 2022 7:03 AM
Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants Compared to Booster Dose of mRNA-1273 in Phase 2/3 Clinical Trial
November 14, 2022 7:01 AM
